Cycloastragenol can negate constitutive STAT3 activation and promote paclitaxel-induced apoptosis in human gastric cancer cells
ConclusionOur results indicate that CAG can function to impede STAT3 activation in human gastric tumor cells and therefore it may be a suitable candidate agent for therapy of gastric cancer.Graphical abstract
Source: Phytomedicine - Category: Drugs & Pharmacology Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Diabetes | Drugs & Pharmacology | Endocrinology | Gastric (Stomach) Cancer | Gastroenterology | Heart | Hepatitis | Hypertension | Translocation